| Income Statement |
| Total Revenue | 344.00K |
|
| Revenues (USD) | 344.00K |
| Cost of Revenue | 172.00K |
| Gross Profit | 172.00K |
| Operating Expenses | 25.80M |
| Research and Development Expense | 15.82M |
| Selling, General and Administrative Expense | 9.98M |
| Operating Income | -25.63M |
| Net Income | -23.53M |
| Net Income Common Stock | -23.53M |
| Net Income Common Stock (USD) | -23.53M |
| Consolidated Income | -23.53M |
| Earnings per Basic Share | -0.11 |
| Earnings per Basic Share (USD) | -0.11 |
| Earnings per Diluted Share | -0.11 |
| Earning Before Interest & Taxes (EBIT) | -23.53M |
| Earning Before Interest & Taxes (USD) | -23.53M |
| Weighted Average Shares | 217.80M |
| Weighted Average Shares Diluted | 217.80M |
| Balance Sheet |
| Cash and Equivalents | 23.65M |
| Cash and Equivalents (USD) | 23.65M |
| Investments | 148.41M |
| Investments Current | 88.09M |
| Investments Non-Current | 60.32M |
| Trade and Non-Trade Receivables | 57.00K |
| Current Assets | 119.09M |
| Property, Plant & Equipment Net | 13.61M |
| Total Assets | 193.58M |
| Debt Current | 1.84M |
| Total Debt | 3.25M |
| Current Liabilities | 11.95M |
| Debt Non-Current | 1.41M |
| Total Liabilities | 13.37M |
| Accumulated Retained Earnings (Deficit) | -743.18M |
| Accumulated Other Comprehensive Income | -441.00K |
| Shareholders Equity | 180.20M |
| Shareholders Equity (USD) | 180.20M |
| Assets Non-Current | 74.49M |
| Total Debt (USD) | 3.25M |
| Inventory | 2.03M |
| Liabilities Non-Current | 1.43M |
| Trade and Non-Trade Payables | 1.59M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 1.62M |
| Net Cash Flow / Change in Cash & Cash Equivalents | -10.34M |
| Capital Expenditure | -78.00K |
| Net Cash Flow from Investing | 8.12M |
| Net Cash Flow - Investment Acquisitions and Disposals | 8.63M |
| Net Cash Flow from Operations | -18.44M |
| Effect of Exchange Rate Changes on Cash | -23.00K |
| Share Based Compensation | 3.05M |